Clascoterone cream for moderate to severe acne
Part of Skin clinical trials.
This study tests a new cream (clascoterone) for moderate to severe acne. The cream is applied to the face to reduce pimples and is compared to a placebo (a cream without the active ingredient).
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 12 years old or older.
- You need to have moderate to severe acne on your face, with a certain number of pimples and blackheads/whiteheads.
- You must be committed to using the same skin and hair care products during the study.
- If you can have children, you (or your partner) must agree to use effective birth control during the study and for 3 months after.
- You cannot have other facial skin conditions (like rosacea or eczema) or certain other medical conditions.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new cream called clascoterone for moderate to severe facial acne. It may help reduce pimples and blackheads with fewer side effects than some other treatments.
This trial compares two topical creams, clascoterone and adapalene, to see which works better for mild acne. If you have mild acne and are between 12 and 35, you might be able to join.
This trial tests a cream called KR230109 for mild to moderate facial acne. The goal is to see if the cream is safe and helps reduce pimples and blackheads/whiteheads. You will be asked to use the cream as directed and attend study visits.
This study compares three different gels for treating mild to moderate acne on the face. One gel contains standard acne medication, another adds a steroid, and the third uses a special ingredient from stem cells (called secretome) to see which works best and is safest.
This study tests a new acne treatment called Cabtreo in children and young teens ages 9–11. The treatment combines three ingredients to reduce acne bumps and spots on the face and body.
This trial tests a new combination hormonal pill (a progestogen and low-dose estrogen) to treat moderate acne in women. It may be an option if you have not had success with other acne treatments.
Hear when a new Acne Vulgaris trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.